Daclatasvir Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso Impurity 2 CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1-nitroso-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate . Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso Impurity 2 . We supply Daclatasvir Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144051 |
| CAS No | NA |
| Mol.F. | C18H20FN7O6 |
| Mol.Wt. | 449.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144052 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144053 |
| CAS No | NA |
| Mol.F. | C8H11N5O4 |
| Mol.Wt. | 241.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144054 |
| CAS No | NA |
| Mol.F. | C9H8FN3O3 |
| Mol.Wt. | 225.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144055 |
| CAS No | NA |
| Mol.F. | C17H18N4O7 |
| Mol.Wt. | 390.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144056 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144057 |
| CAS No | NA |
| Mol.F. | C24H24FN5O6 |
| Mol.Wt. | 497.48 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144058 |
| CAS No | NA |
| Mol.F. | C23H22FN5O6 |
| Mol.Wt. | 483.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144059 |
| CAS No | NA |
| Mol.F. | C24H22FN9O8 |
| Mol.Wt. | 583.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144060 |
| CAS No | NA |
| Mol.F. | C6H9N3O5 |
| Mol.Wt. | 203.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144061 |
| CAS No | NA |
| Mol.F. | C7H13N3O5 |
| Mol.Wt. | 219.20 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144062 |
| CAS No | NA |
| Mol.F. | C3H5N3O5 |
| Mol.Wt. | 163.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144063 |
| CAS No | NA |
| Mol.F. | C16H19N5O4 |
| Mol.Wt. | 345.36 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144064 |
| CAS No | NA |
| Mol.F. | C19H16F3N3O4S |
| Mol.Wt. | 439.41 g/mole |
| INV STATUS | UNDER SYNTHESIS |